Inside ProEd

Our take on the latest developments in scientific communications and regulatory affairs.

Proedcomblog

Proed

Recent Insights

How will Dr. Pazdur’s New Role Affect the Future of FDA Advisory Committees?
Navigating the Regulatory Landscape of Prescription Digital Therapeutics (Part 2)
FDA’s Ambitious Priorities Under Commissioner Makary
Unlocking the Potential of Digital Health Therapeutics: FDA-Approved Solutions for Modern Healthcare
From Pilot to Policy: The FDA’s Rapid March Toward AI-Powered Drug Reviews